Thermo Fisher Scientific Inc. (TMO) is continuing to attract investor interest with several financial investment firms, such as GLOBALT Investments LLC, Raleigh Capital Management Inc., and Sierra Summit Advisors LLC, acquiring new positions in the company. The
stock is making steady strides, despite some market performances. A new product launch supports full
lab automation, further showcasing their innovative approach.
Market returns have been stable with investors seeing a
99% return over the past five years.
Thermo Fisher's first-quarter results for 2024 show
EPS outperforming analysts' expectations. The company's
stock performance is broadly tethered to its
strong fundamentals. Despite some stock falls, investors are encouraged by the fact that
Thermo Fisher has navigated economic headwinds with a resilient 2023 performance. The company also
exceeded market returns, with the
stock outperforming the Dow and shareholders earning a 17% CAGR over the last five years.
Thermo Fisher also introduced an innovative mass spectrometer to advance clinical research. The financials are robust, driving the stock's recent rally, and the company's usage of debt is reasonable.
Thermo Fisher Scientific TMO News Analytics from Tue, 12 Sep 2023 07:00:00 GMT to Sun, 16 Jun 2024 11:44:57 GMT -
Rating 8
- Innovation 6
- Information 7
- Rumor -3
